KU Leuven returned for the automated DNA diagnostic spinout's series A round, which follows a $2.3m round in 2016 and $1.5m raised in 2015.
Ugentec, a Belgium-based developer of automated DNA diagnostics software spinout from KU Leuven, closed a $9.3m series A round on Thursday with backers including the university.
Gemma Frisius Fund, a seed partnership of KU Leuven and banking groups KBC and BNP Paribas Fortis, also contributed funding, as did Flemish government-backed investment firm LRM, nanoelectronics research institute Imec, and private investors Annie Vereecken and Herman Verrelst.
Ugentec’s FastFinder DNA analysis platform relies on artificial intelligence to accelerate and improve the accuracy…
